Biodexa Pharmaceuticals (BDRX) announces that at its General Meeting held earlier, both resolutions put to the Company’s shareholders were duly passed.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDRX:
- Biodexa Pharmaceuticals Secures Nasdaq Listing Compliance
- Biodexa Pharmaceuticals regains Nasdaq compliance
- Biodexa Pharmaceuticals Plans Strategic Share Value Adjustment
- Biodexa Pharmaceuticals Submits SEC Filing with Auditors’ Nod
- Biodexa Pharmaceuticals releases patient updates on PFS, OS from MAGIC-1 study